Ethnic variations in the prevalence of metabolic bone disease among HIV-positive patients with lipodystrophy

Jeffrey R. Curtis, Barbara Smith, Michael Weaver, Kathleen Landers, Robert Lopez-Ben, James L. Raper, Michael Saag, Rajesh Venkataraman, Kenneth G. Saag

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

A high prevalence of metabolic bone disease and osteonecrosis among HIV+ patients on highly active antiretroviral therapy (HAART) has been reported in predominantly white cohorts. We examined bone health in an ethnically diverse cohort of 23 African-Americans and 21 non-African-Americans who were mean (standard deviation) age 45 (7) years old, 66% male, and on HAART for 34 (28) months. Non-African-Americans were more likely to have osteopenia or osteoporosis (59%) compared to African-Americans (26%) (p = 0.09). The prevalence of vitamin D insufficiency (65 pg/ml) was 79% and 20%, respectively. Higher mean urinary N-telopeptide levels were found in non-African-Americans [58 (34) nmol BCE/mmol] compared to African-Americans [41 (18) nmol BCE/mmol] (p = 0.09). Magnetic resonance imaging identified one African-American subject (3%) with bilateral asymptomatic hip osteonecrosis. Our findings suggest that the burden of metabolic bone disease in HIV+ patients with HAART-associated lipodystro-phy may be greater in whites than in African-Americans. Studies to examine ethnic variations in bone metabolism are necessary to devise optimal interventions.

Original languageEnglish (US)
Pages (from-to)125-131
Number of pages7
JournalAIDS Research and Human Retroviruses
Volume22
Issue number2
DOIs
StatePublished - Feb 2006
Externally publishedYes

Fingerprint

Lipodystrophy
Metabolic Bone Diseases
African Americans
HIV
Highly Active Antiretroviral Therapy
Osteonecrosis
Bone and Bones
Vitamin D
Osteoporosis
Hip
Magnetic Resonance Imaging
Health

ASJC Scopus subject areas

  • Immunology
  • Virology

Cite this

Curtis, J. R., Smith, B., Weaver, M., Landers, K., Lopez-Ben, R., Raper, J. L., ... Saag, K. G. (2006). Ethnic variations in the prevalence of metabolic bone disease among HIV-positive patients with lipodystrophy. AIDS Research and Human Retroviruses, 22(2), 125-131. https://doi.org/10.1089/aid.2006.22.125

Ethnic variations in the prevalence of metabolic bone disease among HIV-positive patients with lipodystrophy. / Curtis, Jeffrey R.; Smith, Barbara; Weaver, Michael; Landers, Kathleen; Lopez-Ben, Robert; Raper, James L.; Saag, Michael; Venkataraman, Rajesh; Saag, Kenneth G.

In: AIDS Research and Human Retroviruses, Vol. 22, No. 2, 02.2006, p. 125-131.

Research output: Contribution to journalArticle

Curtis, JR, Smith, B, Weaver, M, Landers, K, Lopez-Ben, R, Raper, JL, Saag, M, Venkataraman, R & Saag, KG 2006, 'Ethnic variations in the prevalence of metabolic bone disease among HIV-positive patients with lipodystrophy', AIDS Research and Human Retroviruses, vol. 22, no. 2, pp. 125-131. https://doi.org/10.1089/aid.2006.22.125
Curtis, Jeffrey R. ; Smith, Barbara ; Weaver, Michael ; Landers, Kathleen ; Lopez-Ben, Robert ; Raper, James L. ; Saag, Michael ; Venkataraman, Rajesh ; Saag, Kenneth G. / Ethnic variations in the prevalence of metabolic bone disease among HIV-positive patients with lipodystrophy. In: AIDS Research and Human Retroviruses. 2006 ; Vol. 22, No. 2. pp. 125-131.
@article{2928a45e0f534c4bac27229a9d71311e,
title = "Ethnic variations in the prevalence of metabolic bone disease among HIV-positive patients with lipodystrophy",
abstract = "A high prevalence of metabolic bone disease and osteonecrosis among HIV+ patients on highly active antiretroviral therapy (HAART) has been reported in predominantly white cohorts. We examined bone health in an ethnically diverse cohort of 23 African-Americans and 21 non-African-Americans who were mean (standard deviation) age 45 (7) years old, 66{\%} male, and on HAART for 34 (28) months. Non-African-Americans were more likely to have osteopenia or osteoporosis (59{\%}) compared to African-Americans (26{\%}) (p = 0.09). The prevalence of vitamin D insufficiency (65 pg/ml) was 79{\%} and 20{\%}, respectively. Higher mean urinary N-telopeptide levels were found in non-African-Americans [58 (34) nmol BCE/mmol] compared to African-Americans [41 (18) nmol BCE/mmol] (p = 0.09). Magnetic resonance imaging identified one African-American subject (3{\%}) with bilateral asymptomatic hip osteonecrosis. Our findings suggest that the burden of metabolic bone disease in HIV+ patients with HAART-associated lipodystro-phy may be greater in whites than in African-Americans. Studies to examine ethnic variations in bone metabolism are necessary to devise optimal interventions.",
author = "Curtis, {Jeffrey R.} and Barbara Smith and Michael Weaver and Kathleen Landers and Robert Lopez-Ben and Raper, {James L.} and Michael Saag and Rajesh Venkataraman and Saag, {Kenneth G.}",
year = "2006",
month = "2",
doi = "10.1089/aid.2006.22.125",
language = "English (US)",
volume = "22",
pages = "125--131",
journal = "AIDS Research and Human Retroviruses",
issn = "0889-2229",
publisher = "Mary Ann Liebert Inc.",
number = "2",

}

TY - JOUR

T1 - Ethnic variations in the prevalence of metabolic bone disease among HIV-positive patients with lipodystrophy

AU - Curtis, Jeffrey R.

AU - Smith, Barbara

AU - Weaver, Michael

AU - Landers, Kathleen

AU - Lopez-Ben, Robert

AU - Raper, James L.

AU - Saag, Michael

AU - Venkataraman, Rajesh

AU - Saag, Kenneth G.

PY - 2006/2

Y1 - 2006/2

N2 - A high prevalence of metabolic bone disease and osteonecrosis among HIV+ patients on highly active antiretroviral therapy (HAART) has been reported in predominantly white cohorts. We examined bone health in an ethnically diverse cohort of 23 African-Americans and 21 non-African-Americans who were mean (standard deviation) age 45 (7) years old, 66% male, and on HAART for 34 (28) months. Non-African-Americans were more likely to have osteopenia or osteoporosis (59%) compared to African-Americans (26%) (p = 0.09). The prevalence of vitamin D insufficiency (65 pg/ml) was 79% and 20%, respectively. Higher mean urinary N-telopeptide levels were found in non-African-Americans [58 (34) nmol BCE/mmol] compared to African-Americans [41 (18) nmol BCE/mmol] (p = 0.09). Magnetic resonance imaging identified one African-American subject (3%) with bilateral asymptomatic hip osteonecrosis. Our findings suggest that the burden of metabolic bone disease in HIV+ patients with HAART-associated lipodystro-phy may be greater in whites than in African-Americans. Studies to examine ethnic variations in bone metabolism are necessary to devise optimal interventions.

AB - A high prevalence of metabolic bone disease and osteonecrosis among HIV+ patients on highly active antiretroviral therapy (HAART) has been reported in predominantly white cohorts. We examined bone health in an ethnically diverse cohort of 23 African-Americans and 21 non-African-Americans who were mean (standard deviation) age 45 (7) years old, 66% male, and on HAART for 34 (28) months. Non-African-Americans were more likely to have osteopenia or osteoporosis (59%) compared to African-Americans (26%) (p = 0.09). The prevalence of vitamin D insufficiency (65 pg/ml) was 79% and 20%, respectively. Higher mean urinary N-telopeptide levels were found in non-African-Americans [58 (34) nmol BCE/mmol] compared to African-Americans [41 (18) nmol BCE/mmol] (p = 0.09). Magnetic resonance imaging identified one African-American subject (3%) with bilateral asymptomatic hip osteonecrosis. Our findings suggest that the burden of metabolic bone disease in HIV+ patients with HAART-associated lipodystro-phy may be greater in whites than in African-Americans. Studies to examine ethnic variations in bone metabolism are necessary to devise optimal interventions.

UR - http://www.scopus.com/inward/record.url?scp=33244462660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33244462660&partnerID=8YFLogxK

U2 - 10.1089/aid.2006.22.125

DO - 10.1089/aid.2006.22.125

M3 - Article

C2 - 16478393

AN - SCOPUS:33244462660

VL - 22

SP - 125

EP - 131

JO - AIDS Research and Human Retroviruses

JF - AIDS Research and Human Retroviruses

SN - 0889-2229

IS - 2

ER -